Outset Medical Inc

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

OM$4.23+3.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations

(in thousands, except per share amounts)

Three Months Ended · Nine Months Ended
	September 30,		September 30,
	2024	2023	2024	2023
Revenue:
Product revenue	$20,305	$23,531	$59,971	$80,640
Service and other revenue	8,361	6,831	24,251	19,229
Total revenue	28,666	30,362	84,222	99,869
Cost of revenue:
Cost of product revenue	11,532	16,837	34,680	59,866
Cost of service and other revenue	7,314	6,368	21,725	18,715
Total cost of revenue	18,846	23,205	56,405	78,581
Gross profit	9,820	7,157	27,817	21,288
Operating expenses:
Research and development	8,139	16,076	30,508	44,775
Sales and marketing	15,417	24,720	54,593	74,038
General and administrative	10,103	11,815	34,231	34,892
Total operating expenses	33,659	52,611	119,332	153,705
Loss from operations	(23,839)	(45,454)	(91,515)	(132,417)
Interest income and other income, net	2,149	2,573	7,718	7,889
Interest expense	(6,068)	(3,213)	(18,046)	(9,258)
Loss before provision for income taxes	(27,758)	(46,094)	(101,843)	(133,786)
Provision for income taxes	182	86	495	411
Net loss	$(27,940)	$(46,180)	$(102,338)	$(134,197)
Net loss per share, basic and diluted	$(0.55)	$(0.93)	$(1.98)	$(2.72)
Shares used in computing net loss per share, basic and diluted	50,501	49,913	51,685	49,364

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.